Comparative Assessment of Methylcobalamin and Ascorbic acid on Cognitive Function in Post-Menopausal Women - A Randomized, Double-blind Trial

SRM University0 个研究点目标入组 53 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. MMSE Score 21-24
•2. Menopausal women (taken as complete cessation of menstruation for at least 1 year/12 cycles) who had attained menopause for a period extending over 4 â?? 10 years at the time of inclusion into the study.

•1. MMSE Score 25-30
•2. History of recent or current Estrogen or hormonal replacement therapy
•3. Known hypertensive, diabetic, renal disease, endocrine disorders, overt nutritional deficiency states, anemia, liver disease or those having history of psychiatric illness.
•4. History of Women having estrogen secreting ovarian tumors, for e.g., granulosa and theca cell tumors, tumors of the adrenal gland.
•5. Known history of neurological disorders including CVA, space occupying lesions, epilepsy and developmental anomalies.
•6. Women, who are physically unable to hear, read or understand written or explained instructions properly, or may have a motor deficit that affects writing and drawing skills.
•7. Women, who are already in any of the antioxidant or dietary supplement therapy.

发起方